Prof Andrew Gorringe | Scientific Leader
P.H.E. | United Kingdom

Prof Andrew Gorringe, Scientific Leader, P.H.E.

Andrew Gorringe is a Scientific Leader at PHE. He leads the Pathogen Immunology Group which is developing novel methods of characterising antibody and complement interactions with bacterial pathogens. He has performed leading research on the role of fimbriae in B. pertussis vaccines and current research is exploring the role of B. pertussis strain diversity and its effect on vaccine immune responses. He has experience of vaccine development leading the development of a meningococcal vaccine from laboratory proof of concept to phase I clinical trial.


Oct 30th Day 2 @ 17:05

Panel: Establishing and using immune correlates of protection for vaccine licensure.

last published: 16/Sep/19 14:05 GMT

back to speakers

Sign Up for Event Updates